Beacon Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Beacon Financial Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,395	Closed	-$268K	–	340
2025 Q1	$268K	Buy	4,395 +98	+2%	+$5.71K	0.03%	295
2024 Q4	$243K	Sell	4,297 -722	-14%	-$40.3K	0.03%	304
2024 Q3	$260K	Buy	+5,019	New	+$235K	0.03%	294
2024 Q2	–	Sell	-4,685	Closed	-$254K	–	322
2024 Q1	$254K	Sell	4,685 -57,980	-93%	-$2.95M	0.03%	296
2023 Q4	$3.22M	Sell	62,665 -2,156	-3%	-$113K	0.39%	68
2023 Q3	$4M	Sell	64,821 -598	-0.9%	-$36.6K	0.57%	58
2023 Q2	$4.19M	Sell	65,419 -528	-0.8%	-$35.4K	0.57%	59
2023 Q1	$4.63M	Sell	65,947 -2,398	-4%	-$169K	0.65%	54
2022 Q4	$4.92M	Sell	68,345 -644	-0.9%	-$48.6K	0.67%	47
2022 Q3	$4.95M	Sell	68,989 -439	-0.6%	-$31.8K	0.77%	37
2022 Q2	$5.46M	Sell	69,428 -679	-1%	-$51.7K	0.81%	37
2022 Q1	$5.13M	Buy	70,107 +484	+0.7%	+$32.5K	0.68%	48
2021 Q4	$4.31M	Sell	69,623 -688	-1%	-$40.4K	0.56%	56
2021 Q3	$4.26M	Buy	70,311 +47,728	+211%	+$3.14M	0.57%	56
2021 Q2	$4.7M	Sell	22,583 -46,779	-67%	-$3.05M	0.67%	49
2021 Q1	$4.57M	Hold	69,362	–	–	0.72%	43
2020 Q4	$4.57M	Buy	69,362 +262	+0.4%	+$16.1K	0.72%	43
2020 Q3	$4.17M	Sell	69,100 -1,277	-2%	-$76.9K	0.75%	43
2020 Q2	$4.07M	Buy	70,377 +593	+0.8%	+$35.5K	0.78%	44
2020 Q1	$3.8M	Buy	69,784 +1,847	+3%	+$113K	0.83%	41
2019 Q4	$3.93M	Sell	67,937 -5,340	-7%	-$306K	0.49%	51
2019 Q3	$3.5M	Hold	73,277	–	–	0.6%	54
2019 Q2	$3.5M	Sell	73,277 -5,953	-8%	-$277K	0.6%	55
2019 Q1	$3.7K	Sell	79,230 -5,502	-6%	-$274K	0.61%	48
2018 Q4	$3.22M	Sell	84,732 -4,286	-5%	-$230K	0.6%	50
2018 Q3	$3.96M	Sell	89,018 -1,350	-1%	-$80.1K	0.67%	46
2018 Q2	$3.66M	Sell	90,368 -2,076	-2%	-$112K	0.62%	51
2018 Q1	$3.6M	Sell	92,444 -2,151	-2%	-$138K	0.61%	50
2017 Q4	$4.12M	Sell	94,595 -1,893	-2%	-$118K	0.72%	49
2017 Q3	$3.98M	Buy	96,488 +1,541	+2%	+$90K	0.72%	49
2017 Q2	$3.76M	Sell	94,947 -670	-0.7%	-$36.5K	0.71%	49
2017 Q1	$3.5M	Buy	95,617 +2,614	+3%	+$143K	0.67%	50
2016 Q4	$3.07M	Buy	93,003 +14,838	+19%	+$811K	0.62%	55
2016 Q3	$2.76M	Sell	78,165 -90	-0.1%	-$5.78K	0.58%	54
2016 Q2	$2.59M	Sell	78,255 -803	-1%	-$56.7K	0.57%	49
2016 Q1	$2.76M	Buy	79,058 +68,188	+627%	+$4.3M	0.6%	51
2015 Q4	$346K	Buy	10,870 +370	+4%	+$24.5K	0.08%	137
2015 Q3	$314K	Hold	10,500	–	–	0.08%	141
2015 Q2	$367K	Sell	10,500 -1,231	-10%	-$81.1K	0.08%	133
2015 Q1	$690K	Buy	11,731 +4,731	+68%	+$296K	0.15%	89
2014 Q4	$352K	Sell	7,000 -4,297	-38%	-$242K	0.07%	131
2014 Q3	$539K	Buy	11,297 +4,297	+61%	+$215K	0.12%	115
2014 Q2	$308K	Hold	7,000	–	–	0.07%	143
2014 Q1	$283K	Hold	7,000	–	–	0.06%	152
2013 Q4	$271K	Sell	7,000 -18,115	-72%	-$923K	0.05%	161
2013 Q3	$1.16M	Buy	+25,115	New	+$1.1M	0.25%	82

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Beacon Financial Group's BMY Position: Q2 2025 in Review

Beacon Financial Group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,395 shares — an estimated $268K sold.

Beacon Financial Group first reported a position in BMY in Q3 2013 and held it in 46 quarters. The position peaked at $5.46M in Q2 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Beacon Financial Group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Beacon Financial Group sold 4,395 Bristol-Myers Squibb shares in Q2 2025, an estimated $268K.
Beacon Financial Group first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 46 quarters.
Beacon Financial Group's Bristol-Myers Squibb position peaked at $5.46M in Q2 2022.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Beacon Financial Group's 13F filing for Q2 2025, filed 9 Jul 2025.